MTOR and osteosarcoma: According to another study that used qRT-PCR and western blot techniques, CBR3-AS1 modifies the miR-140-5p/DDX54-NUCKS1-mTOR signaling pathway network, hence potentially contributing to an oncogenic function in osteosarcoma [27].